← Back to Search

Cereset for Health Care Workers

N/A
Waitlist Available
Led By Charles H Tegeler, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Unable, unwilling, or incompetent to provide informed consent
Physically unable to come to the study visits
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if providing staff in one hospital unit with a specific program called CR can improve the quality of care in that unit.

Who is the study for?
This trial is for healthcare workers in a hospital nursing unit who may be experiencing anxiety, stress, depression, sleep disorders or insomnia. Specific eligibility criteria are not provided.
What is being tested?
The study is testing the impact of Cereset Research (CR) on quality measures within a single hospital nursing unit after it's offered to staff members.
What are the potential side effects?
Since the intervention involves an implementation process rather than a medical treatment, side effects are not specified as they would be with drug trials.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to give informed consent.
Select...
I cannot physically attend the study visits.
Select...
I weigh more than 400 pounds.
Select...
I have a known seizure disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent of ortho trauma unit staff who complete Cereset intervention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Cereset Intervention GroupActive Control1 Intervention
This system uses the same core technology and algorithms to echo brainwaves in real-time using audible tones, as with High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM).
Group II: No InterventionActive Control1 Intervention
No Intervention

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for improving the well-being of health care workers, such as the Cereset (CR) therapy being studied, typically focus on stress reduction, mental health support, and enhancing job performance. These treatments often work by promoting relaxation, improving sleep quality, and reducing anxiety and burnout through neurofeedback and other cognitive-behavioral techniques. This is crucial for health care workers as it helps maintain their mental and emotional health, leading to better patient care, increased job satisfaction, and reduced turnover rates.

Find a Location

Who is running the clinical trial?

Susanne Marcus Collins Foundation, Inc.UNKNOWN
1 Previous Clinical Trials
94 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,397 Previous Clinical Trials
2,460,099 Total Patients Enrolled
38 Trials studying Depression
35,996 Patients Enrolled for Depression
Charles H Tegeler, MDPrincipal InvestigatorWake Forest University Health Sciences
6 Previous Clinical Trials
592 Total Patients Enrolled
~16 spots leftby Jul 2025